ARQ 092 enhances the Efficacy of Paclitaxel, Lapatinib, Trastuzumab, Trametinib, and ARQ 087 both in Cancer Cell Lines and Mouse Xenograft Cancer Models

Thursday, November 12, 2015   https://www.arqule.comPosters and Presentations

Questions or Concerns?

Please feel free to contact by one of the methods below

Online Form   Call (781) 994-0300